Hochschulschrift
Furan- and pyran-based heterocycles as subtype-selective ligands of the estrogen receptor : synthesis and biological characterisation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Regensburg, Univ., Diss., 2005
- Schlagwort
-
Antiöstrogene ; Brustkrebs ; Östrogenrezeptor ; Furanderivate ; Pyranderivate ; Heterocyclische Verbindungen ; Ligand
Krebs
Onkologie
- Urheber
- URN
-
urn:nbn:de:bvb:355-opus-5796
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Design, synthesis, and evaluation of bivalent estrogen ligands
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Synthesis and characterization of subtype-selective estrogen receptor ligands and their application as pharmacological tools : cross-talk between estrogen and NPY Y1 receptors in human breast cancer cells
Ligands specify estrogen receptor alpha nuclear localization and degradation
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Impact of estradiol, estrogen receptor subtype-selective agonists and genistein on energy homeostasis
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Utilizing MEDT analysis of [3 + 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Chemoselective Post‐Synthesis Modification of Pyridyl‐Substituted, Aromatic Phosphorus Heterocycles: Cationic Ligands for Coordination Chemistry
Design, synthesis, and evaluation of bivalent estrogen ligands
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Synthesis and characterization of subtype-selective estrogen receptor ligands and their application as pharmacological tools : cross-talk between estrogen and NPY Y1 receptors in human breast cancer cells
Ligands specify estrogen receptor alpha nuclear localization and degradation
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Impact of estradiol, estrogen receptor subtype-selective agonists and genistein on energy homeostasis
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Utilizing MEDT analysis of [3 + 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Chemoselective Post‐Synthesis Modification of Pyridyl‐Substituted, Aromatic Phosphorus Heterocycles: Cationic Ligands for Coordination Chemistry
Design, synthesis, and evaluation of bivalent estrogen ligands
Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands
Synthesis and characterization of subtype-selective estrogen receptor ligands and their application as pharmacological tools : cross-talk between estrogen and NPY Y1 receptors in human breast cancer cells
Ligands specify estrogen receptor alpha nuclear localization and degradation
Tissue specific estrogen action : novel mechanisms, novel ligands, novel therapies
Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Impact of estradiol, estrogen receptor subtype-selective agonists and genistein on energy homeostasis
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Utilizing MEDT analysis of [3 + 2] cycloaddition reaction: x-ray crystallography of spirooxindole linked with thiophene/furan heterocycles and triazole framework
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes